Demographic and clinical findings:
In total, 60 (53%) patients were women and 53 (47%) men. The mean age
of the participants was 3.6 ± 1.2 years (range: 3 months to 18 years).
Thirty (26.5%) patients had a body weight below the 10th percentile for
age. Moreover, 93 (82.3%) were diagnosed with CAP and 18 (15.9%) with
CCAP. There was no significant difference in sex between the two groups.
In total, 15 (13%) patients had a history of previous CAP. Further,
during admission, 105 (92.9%) had cough; 91 (80.5%), fever; and 8
(7.07%), chest pain. Then, 43 (38.05%) patients received peroral
antibiotic–antiviral therapy (n=12, amoxicillin–clavulanic acid; n=8,
cephalosporins; n=14, macrolides; n=7, amoxicillin–clavulanic and
macrolides; and n=2, oseltamivir) before admission. Antibiotic use
before admission and history of pneumonia did not significantly differ
between the CAP and CCAP groups (p=0.250, 0.223, 0.324, 0.659, 0.253,
and 0.546, respectively). The average CCAP patients’ age was 4.2±3.3
years. The age of CAP patients was greater than the mean age (2.8±2.1
years) (p=0.012). In our study, none of the patients presented with
severe malnutrition. Although patients diagnosed with CCAP commonly have
a body weight below the 10th percentile for age, the 2 groups did not
significantly differ (p=0.024). Respiratory distress (tachypnea and
retraction) and hypoxia (SaO2 <92%) were significantly more
common in patients diagnosed with CCAP at presentation than in those
diagnosed with CAP (p<0.001 and<0.001, respectively)
(Table-1). None of the CAP and CCAP patients died due to local and
systemic complications during hospitalization (Table-1).